| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | 0.0024 | 0.9 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | 0.002 | 0.9 |
| mRNA | TAK-715 | GDSC1000 | pan-cancer | AAC | -0.0023 | 0.9 |
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | 0.0022 | 0.9 |
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | 0.0022 | 0.9 |
| mRNA | BRD9647 | CTRPv2 | pan-cancer | AAC | -0.0023 | 1 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | 0.0021 | 1 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | -0.0022 | 1 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.017 | 1 |
| mRNA | MG-132 | CTRPv2 | pan-cancer | AAC | 0.0034 | 1 |